Avéli Cellulite Device Cleared in Australia

Revelle Aesthetics’ Avéli is now cleared for long-term reduction in the appearance of cellulite in Australia.

"Cellulite is one of the most common skin conditions, prevalent in up to 90% of women worldwide. And much like in the United States, it's a common aesthetic concern in Australia that can affect the self-esteem of those bothered by it and who cannot find an effective solution," says Caroline Van Hove, President & CEO of Revelle Aesthetics, in a news release. "With our Australian clearance, we establish our global footprint and look forward to bringing a real cellulite solution to women around the world."

Avéli uses a targeted subcision method that allows providers to identify which septa under the skin are causing a cellulite dimple, and then confirms this in real time.

"As we prepare our Australian go-to-market plan, we are committed to building upon the scientific credibility and meaningful real-world results achieved by hundreds of expert providers since launching in the United States and look forward to replicating this success overseas," said Benjamin Bishop, Revelle Aesthetics' Chief Commercial Officer.